NCT00205660View on ClinicalTrials.gov

Changes in Adiposity, Metabolic Measures From Atypicals to Aripiprazole

PHASE4CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions
SchizophreniaType 2 Diabetes Mellitus
Interventions
OTHER

Stayers

Participants remain on their current antipsychotic.

OTHER

Switchers

Subjects are randomized to switch to aripiprazole from their current antipsychotic.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

Bristol-Myers Squibb
All Listed Sponsors
collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Washington University School of Medicine

OTHER